ArticleStem cell research & therapy2017

Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance.

Kunal H Bhatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.